Category: Cannabis Studies

Peer-reviewed studies covering cannabis and cannabis compounds.

Study: THC/CBD Powder More Than Doubles Cannabinoid Bioavailability Compared to Oil-Based Drops

A new study published in the Journal of Cannabis Research found that a powdered formulation of THC and CBD more than doubles cannabinoid bioavailability compared to traditional oil-based drops. The study involved 14 healthy adults who received two different oral formulations containing 8 mg of THC and 8 mg of CBD: one as standard oil …

Continue reading

Study: CBD and CBDV Show Potent Antifungal Effects, Including Against Drug-Resistant Pathogens

A new study published in the journal PLOS Neglected Tropical Diseases found that the cannabinoids cannabidiol (CBD) and cannabidivarin (CBDV) display strong antifungal activity, including against the World Health Organization–listed priority pathogen Cryptococcus neoformans. Researchers from Macquarie University, the University of Sydney, and Monash University in Australia tested five phytocannabinoids and found that CBD and …

Continue reading

Study: CBD Reduces Thunderstorm-Related Anxiety in Cats, Including Undesirable Urination

A new peer-reviewed study published in the journal Animals found that cannabidiol (CBD) may significantly reduce fear-related behaviors in domestic cats exposed to simulated thunderstorms. Researchers from Japan’s Center for Research of Developmental Disorders tested 40 healthy cats in a laboratory setting designed to mimic a thunderstorm. The animals, none of which had prior exposure …

Continue reading

Large Multinational Trial Underway to Determine if CBD May Improve Behavioral Issues in People With Tuberous Sclerosis

A large international trial is underway to determine whether CBD can help improve behavioral symptoms in people with tuberous sclerosis complex (TSC), a condition that affects about 90% of patients with a group of neuropsychiatric symptoms known as TAND. The study, called EpiCom, is a phase 3b/4 open-label trial taking place at around 20 sites …

Continue reading

Study: Psilocybin Reduces Depression in Veterans With Severe Treatment-Resistant Depression, With Some Effects Lasting a Year

A new pilot study suggests that a single dose of psilocybin may significantly reduce depression symptoms in military veterans with severe treatment-resistant depression (TRD), with effects lasting up to a year in some patients. Researchers from Ohio State University and Stanford University School of Medicine tracked 15 veterans who received a 25 mg dose of …

Continue reading

Study: Oral THC More Effective Than CBD or THC+CBD for Acute Inflammatory Pain

A new study from researchers at Johns Hopkins University School of Medicine finds that oral delta-9-tetrahydrocannabinol (THC) is more effective than cannabidiol (CBD), or a combination of the two, in reducing pain sensitivity associated with acute inflammation. The study, published in The Journal of Pharmacology and Experimental Therapeutics, used a carrageenan-induced inflammatory pain model in …

Continue reading

Study Finds Hemp Seed Oil May Help Treat Antibiotic-Resistant Skin Infections in Pets

According to the results of a new study, hemp seed oil may be an effective and safe treatment for localized skin infections in small animals, including those caused by antibiotic-resistant bacteria. Researchers from the University of Milan, the University of Perugia, and the University of Copenhagen tested the antimicrobial properties of Cannabis sativa (hemp) seed …

Continue reading

Study: Cannabidivarinic Acid (CBDVA) Found to Deter Aphids, Offering Natural Pest Control Option

Researchers from Colorado State University, Cornell University and the USDA have found that a rare cannabinoid called cannabidivarinic acid (CBDVA) significantly reduces aphid populations, suggesting it could serve as a natural insecticide for hemp and cannabis crops. In the study, published in the Journal of Cannabis Research and archived by the National Library of Medicine, …

Continue reading

Study: CBD May Curb Methamphetamine Relapse by Targeting Brain’s Dopamine Receptors

A new study finds that cannabidiol (CBD) may help reduce relapse behaviors in methamphetamine addiction by interacting with dopamine receptors in a key brain region linked to memory and emotion. Researchers from the Iranian Academy of Medical Sciences and three Iranian universities found that CBD’s impact on methamphetamine-seeking behavior is partly mediated by D2-like dopamine …

Continue reading

Majority of U.S. Sports Fans Support THC and CBD Sponsorships, Survey Finds

A new survey reveals that most sports fans in legal marijuana states are open to cannabis sponsorships across major professional leagues, with support even higher for CBD than THC. The poll, conducted by Performance Research in partnership with Full Circle Research, asked over 1,000 U.S. adults—ages 21 and older who regularly or occasionally watch pro …

Continue reading